Ante-partum and post-partum markers of metabolic syndrome in pre-eclampsia

Journal of Human Hypertension

Volumn 25, Issue 1, 2011, Pages 11-17

  Lei, Q ^a   Lv, L J ^a   Zhang, B Y ^a   Wen, J Y ^a   Liu, G C ^a   Lin, X H ^a   Niu, J M ^a  

^a Guangdong Women and Children's Hospital   (China)

Author keywords

cardiovascular disease; dyslipidemia; insulin resistance; metabolic syndrome; pre eclampsia

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DYSLIPIDEMIA; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; METABOLIC SYNDROME X; PREECLAMPSIA; PRENATAL PERIOD; PROSPECTIVE STUDY; PUERPERIUM; TRIACYLGLYCEROL BLOOD LEVEL; VENOUS BLOOD;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; COHORT STUDIES; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; METABOLIC SYNDROME X; POSTPARTUM PERIOD; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PROSPECTIVE STUDIES; RISK FACTORS; TRIGLYCERIDES;

EID: 78650177225     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2010.29     Document Type: Article

References (38)

1. Bonney EA. Preeclampsia: A view through the danger model. J Reprod Immunol 2007; 76: 68-74. (Pubitemid 350100873)
2. ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33. Int J Gynecol Obstet 2002; 77: 67-75.
3. Buchbinder A, Sibai BM, Caritis S, Macpherson C, Hauth J, Lindheimer MD et al. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol 2002; 186: 66-71. (Pubitemid 34093742)
4. Harskamp RE, Zeeman GG. Preeclampsia: At risk for remote cardiovascular disease. Am J Med Sci 2007; 334: 291-295. (Pubitemid 351339288)
5. Yü cesoy G, Ozkan S, Bodur H, Tan T, Cali1kan E, Vural B et al. Maternal and prenatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: A seven year experience of a tertiary care center. Arch Gynecol Obstet 2005; 273: 43-49.
6. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/ eclampsia: A systematic review and meta-analyses. Am Heart J 2008; 156: 918-930.
7. Lykke JA, Langhoff-Roos J, Sibai BM, Funai EF, Triche EW, Paidas MJ. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 2009; 53: 944-951.
8. Kajantie E, Eriksson JG, Osmond C, Thornburg K, Barker DJ. Pre-eclampsia is associated with increased risk of stroke in the adult offspring: The Helsinki birth cohort study. Stroke 2009; 40: 1176-1180.
9. Villa PM, Laivuori H, Kajantie E, Kaaja R. Free fatty acid profiles in preeclampsia. Prostaglandins Leukot Essent Fatty Acids 2009; 81: 17-21.
10. Soonthornpun K, Soonthornpun S, Wannaro P, Setasuban W, Thamprasit A. Insulin resistance in women with a history of severe pre-eclampsia. J Obstet Gynaecol Res 2009; 35: 55-59.
11. Isezuo SA, Ekele BA. Comparison of metabolic syndrome variables among pregnant women with and without eclampsia. J Natl Med Assoc 2008; 100: 1059-1162.
12. Yen SSE. Endocrine regulation of metabolic homeostasis during pregnancy. Clin Obstet Gynecol 1973; 16: 130-147.
13. Bodnar LM, Ness RB, Markovic N, Roberts JM. The risk of preeclampsia rises with increasing prepregnancy body mass index. Ann Epidemiol 2005; 15: 475-482. (Pubitemid 40982122)
14. Smith GN, Walker MC, Liu A, Wen SW, Swansburg M, Ramshaw H et al. A history of preeclampsia identifies women who have underlying cardiovascular risk factors. Am J Obstet Gynecol 2009; 200: 58. e1-e8.
15. Hubel CA, McLaughlin MK, Evans RW, Hauth BA, Sims CJ, Roberts JM. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am J Obstet Gynecol 1996; 174: 975-982. (Pubitemid 26111679)
16. Saarelainen H, Laitinen T, Raitakari OT, Juonala M, Heiskanen N, Lyyra-Laitinen T et al. Pregnancy-related hyperlipidemia and endothelial function in healthy women. Circ J 2006; 70: 768-772. (Pubitemid 43797790)
17. Barbieri RL. Endocrine disorders in pregnancy. In: Yen SSC, Jaffe RB, Barbieri RL (eds). Reproductive Endocrinology. WB Saunders Co: Philadelphia, PA, 1999.
18. Rademacher TW, Gumaa K, Scioscia M. Preeclampsia, insulin signalling and immunological dysfunction: A fetal, maternal or placental disorder. J Reprod Immunol 2007; 76: 78-84. (Pubitemid 350100882)
19. Masuyama H, Nakatsukasa H, Takamoto N, Hiramatsu Y. Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia. J Clin Endocrinol Metab 2007; 92: 2672-2679. (Pubitemid 47037375)
20. Girouard J, Giguère Y, Moutquin JM, Forest JC. Previous hypertensive disease of pregnancy is associated with alterations of markers of insulin resistance. Hypertension 2007; 49: 1056-1062. (Pubitemid 351664330)
21. Roberts JM, Gammill H. Insulin resistance in preeclampsia. Hypertension 2006; 47: 341-342. (Pubitemid 43740271)
22. Potter JM, Nestel PJ. The hyperlipidemia of pregnancy in normal and complicatedpregnancies. Am J Obstet Gynecol 1979; 33: 165-170.
23. Herrera E, Lasuncion MA, Gomez-Coronado D, Aranda P, Lopez-Luna P, Maier I. Role of lipoprotein lipase activity on lipoprotein metabolism and the fate of circulating triglycerides in pregnancy. Am J Obstet Gynecol 1988; 158: 1575-1583.
24. Laivuori H, Tikkanen MJ, Ylikorkala O. Hyperinsulinemia 17 years after preeclamptic first pregnancy. J Clin Endocrinol Metab 1996; 81: 2908-2911. (Pubitemid 26323884)
25. Ray JG, Diamond P, Singh G, Bell CM. Brief overview of maternal triglycerides as a risk factor for preeclampsia. BJOG 2006; 113: 379-386.
26. Villa PM, Laivuori H, Kajantie E, Kaaja R. Free fatty acid profiles in preeclampsia. Prostaglandins Leukot Essent Fatty Acids 2009; 81: 17-21.
27. Endresen J, Lorentzen B, Henriksen T. Increased lipolytic activity and high ratio of free fatty acids to albumin in sera from women with preeclampsia leads to triglyceride accumulation in cultured endothelial cells. Am J Obstet Gynecol 1992; 167: 440-447.
28. Fasshauer M, Seeger J, Waldeyer T, Schrey S, Ebert T, Kratzsh J et al. Serum levels of the adipokineadipocyte fatty-acid-binding protein are increased in preeclampsia. Am J Hypertens 2008; 21: 582-586. (Pubitemid 351589677)
29. Kajantie E, Kaaja R, Ylikorkala O, Andersson S, Laivuori H. Adiponectin concentrations in maternal serum: Elevated in preeclampsia but unrelated to insulin sensitivity. J Soc Gynecol Investig 2005; 12: 433-439. (Pubitemid 41242383)
30. Sharma A, Satyam A, Sharma JB. Leptin, IL-10 and inflammatory markers (TNF-alpha, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women. Am J Reprod Immunol 2007; 58: 21-30. (Pubitemid 46939024)
31. Clausen T, Djurovic S, Henriksen T. Dyslipidemia in early second trimester is mainly a feature of women with early onset pre-eclampsia. BJOG 2001; 108: 1081-1087. (Pubitemid 32971743)
32. Edlow AG, Srinivas SK, Elovitz MA. Investigating the risk of hypertension shortly after pregnancies complicated by preeclampsia. Am J Obstet Gynecol 2009; 200: E60-e62.
33. Schobel HP, Fischer T, Heuszer K, Geiger H, Schmieder RE. Preeclampsia-a state of sympathetic overactivity. N Engl J Med 1996; 335: 1480-1485. (Pubitemid 26376680)
34. Bartha JL, González-Bugatto F, Fernández-Macías R, González-González NL, Comino-Delgado R, Hervías- Vivancos B. Metabolic syndrome in normal and complicated pregnancies. Eur J Obstet Gynecol Reprod Biol 2008; 137: 178-184. (Pubitemid 351423463)
35. Ray JG, Vermeulen MJ, Schull MJ, McDonald S, Redelmeier DA. Metabolic syndrome and the risk of placental dysfunction. J Obstet Gynaecol Can 2005; 27: 1095-1101.
36. Wilson BJ, Watson MS, Prescott GJ, Sunderland S, Campbell DM, Hannaford P et al. Hypertensive diseases in pregnancy and risk of hypertension and stroke in later life: Results from cohort study. BMJ 2003; 326: 845-851.
37. Thadhani R, Stampfer MJ, Hunter DJ, Manson JE, Solomon CG, Curhan GC. High body mass index and hypertotal cholesterol emia: Risk of hypertensive disorders of pregnancy. Obstet Gynecol 1999; 94: 543-550. (Pubitemid 29460937)
38. Harskamp RE, Zeeman GG. Preeclampsia: At risk for remote cardiovascular disease. Am J Med Sci 2007; 334: 291-295. (Pubitemid 351339288)